News
Omicron Specific Vaccine Trials Get Rolled Out By Moderna
Moderna, the US biotech firm, has announced that it has initiated clinical trials of a booster that is especially designed to fight out the...
News
Aposave rebrands to Abacus Medicine Pharma Services
Abacus Medicine Pharma Services is the new name for the healthcare and pharma services company previously known as Aposave.
Simon Estcourt, Managing Director, Abacus Medicine...
Drug Research
Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research
Lifebit announces a long-term partnership where Lifebit's technology, Lifebit CloudOS, will power a cloud-based Trusted Research Environment (TRE) to serve as the scalable and...
News
By Winter 2023 Moderna eyes Combined COVID 19 And Flu Shot
According to Moderna’s CEO, Stephane Bancel, the company is aiming to bring to the market a combination of COVID-19 and influenza booster in the...
News
Novartis And Pfizer Stand Tall To Disrupt Biosimilar Space
As per GlobalData’s Thematic Research ecosystem, pharmaceutical giants Novartis and Pfizer are the best-positioned companies to take advantage of future biosimilars in the pharma...
Clinical Trials
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
Pfizer Inc. and BioNTech SE announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate...
Press Releases
Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19
Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read